• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Beware Antitrust Regulations When Considering Healthcare Mergers

by Steven M. Harris, Esq. • April 5, 2015

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Beware Antitrust Regulations When Considering Healthcare MergersThe Antitrust Division of the Federal Trade Commission (FTC), the Department of Justice (DOJ), and state attorneys general have been aggressively enforcing antitrust laws in the healthcare market. The FTC views the challenges to certain healthcare transactions as an important element in controlling the cost of healthcare where the transactions have, in its view, an anticompetitive affect on the market. Navigating the antitrust laws is important for healthcare systems, hospitals and physician practices that are looking at consolidation, mergers or other forms of collaboration as a means to meet the current economic constraints and other challenges in the healthcare industry.

You Might Also Like

  • Navigating a Healthcare Transaction
  • Changes to Federal Laws May Mean Better Collaboration Between Healthcare Providers
  • How New Healthcare Price Transparency Rules May Affect Your Otolaryngology Services at Hospitals
  • CVS–Aetna Merger May Reshape Healthcare Delivery in the U.S.
Explore This Issue
April 2015

The discussions and activities associated with entering into a merger or other collaboration between and among providers must comply with the antitrust laws, which prohibit any concerted action that suppresses, or that facilitates the suppression of, competition. A number of federal antitrust laws exist and are generally enforced by the FTC and the DOJ. State antitrust laws are enforced by the state attorney general.

Transaction Discussion & Negotiation

The meetings, discussions and communications among providers in furtherance of a potential merger may constitute concerted action for antitrust purposes when they involve independently practicing physicians and physician groups or healthcare entities that may be viewed as competitors. Accordingly, any discussions or actions that could lead to anticompetitive conduct need to be avoided.

Areas that will create significant risk during the analysis and negotiation of a potential merger include:

  1. Any discussion or dissemination of the current fees charged by providers, desired reimbursement levels or possible changes in those fees or levels;
  2. Any agreement on a specific method of charging for services;
  3. Any discussion of limiting the geographic area served, the entities to be solicited, the services provided by a provider, or any discussion regarding market allocation;
  4. Any suggestion of boycott of, or retaliatory action against, a managed care organization, insurer, or other entity; and
  5. Sharing of payer contracts that the providers have in common.

At the beginning of any merger analysis and negotiation, transaction and antitrust counsel should provide or facilitate an evaluation of the potential antitrust implications and may prepare and circulate a checklist that clearly identifies permissible and impermissible discussion topics.

Steven M. Harris, EsqFalling within a safety zone allows a greater degree of comfort that the transaction will not be deemed to violate antitrust laws.

Level of Integration

As providers face increasing challenges seeking reimbursement for services, many are looking for ways to collaborate to facilitate improved payer arrangements. Agreements on prices or price levels for patients are per se illegal under antitrust laws, but joint price negotiations by competing healthcare providers may be permissible if properly evaluated to determine (a) if there is sufficient financial and clinical integration and (b) if the agreement is reasonably necessary to accomplish the procompetitive benefits of the integration.

Pages: 1 2 3 | Single Page

Filed Under: Departments, Legal Matters Tagged With: antitrust, legal, mergersIssue: April 2015

You Might Also Like:

  • Navigating a Healthcare Transaction
  • Changes to Federal Laws May Mean Better Collaboration Between Healthcare Providers
  • How New Healthcare Price Transparency Rules May Affect Your Otolaryngology Services at Hospitals
  • CVS–Aetna Merger May Reshape Healthcare Delivery in the U.S.

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • Excitement Around Gene Therapy for Hearing Restoration

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939